Kristin Yunis
Nurse Practitioner · North Port, FLNPI 1376972679
Payments from drug & device makers
Across 41 payments — averaging $21.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$171
- Sun Pharmaceutical Industries Inc.$155
- Galderma Laboratories, L.p.$87
- AbbVie$74
- Amgen$74
- E.r. Squibb & Sons, L.L.C.$70
- plus $248 from 10 others
What the payments were for
- Food & beverage$879100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $171 |
| Sun Pharmaceutical Industries Inc. | 7 | $155 |
| Galderma Laboratories, L.p. | 4 | $87 |
| AbbVie | 3 | $74 |
| Amgen | 3 | $74 |
| E.r. Squibb & Sons, L.L.C. | 3 | $70 |
| Novartis | 2 | $40 |
| Sanofi | 1 | $35 |
| Almirall LLC | 1 | $34 |
| Merz North America, Inc. | 1 | $30 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Genentech, Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $15 |
| Incyte Corporation | 1 | $14 |
How this compares
$879 in reported general payments places this provider in the 70th percentile of 8,290 nurse practitioner providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $84,195 |
| Fluorouracil | 46 | $3,133 |
| Ketoconazole | 152 | $1,964 |
| Mupirocin | 234 | $1,763 |
| Fluocinonide | 34 | $1,504 |
| Clobetasol Propionate | 25 | $1,451 |
| Doxycycline Hyclate | 205 | $1,327 |
| Clindamycin Phosphate | 25 | $1,173 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 12 | $1,096 |
| Gentamicin Sulfate | 25 | $1,053 |
| Triamcinolone Acetonide | 74 | $759 |
| Metronidazole | 15 | $592 |
| Betamethasone Dipropionate | 18 | $506 |
| Ammonium Lactate | 12 | $261 |
| ValacyclovirValacyclovir Hcl | 19 | $231 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in North Port
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.